November 19, 2026 · American heart journal · DOI: 10.1016/j.ahj.2026.107665

Rationale and Design of the MICRA-HYBRID Trial: Multivessel Minimally Invasive Coronary Bypass Grafting as HYBRID Revascularization Versus Conventional Off-pump Coronary Artery Bypass Grafting.

Listen to this summary

The MICRA-HYBRID trial asks whether multivessel hybrid coronary revascularization, combining minimally invasive LAD and circumflex grafting with percutaneous RCA intervention, is superior to conventional off-pump CABG in patients with three-vessel coronary artery disease. In this dual-center randomized trial of 250 patients, the primary endpoint is a 30-day "textbook outcome," a composite of freedom from mortality, major surgical and cardiac complications, and prolonged hospitalization. Secondary endpoints include quality of life, pulmonary recovery, short-term costs, and 5-year major adverse cardiac and cerebrovascular events.

Ismail Cenik, Wouter Oosterlinck, Joost Ter Woorst, Mohammed Soliman-Hamad, Koen Teeuwen, Bart Koene, Steven Jacobs, Johan Bennett, Marcel van 't Veer, Pim Tonino, Ferdi Akca

This is one of 33,000+ journals available on OSLR. Try it free for 14 days.

Free 14-day trial. 33,000+ journals. Cancel anytime.

14-day free trial. No commitment.

“

"Oslr has become part of my weekly routine on my day off. The clinical relevance of the summaries is outstanding — I'd rate it 9/10. Being able to consume research hands-free is a huge advantage for busy physicians."

Dr. Jennifer Thompson

Dr. Jennifer Thompson

Portland, OR

Stay current without falling behind

33,000+ journals. 3-minute audio summaries. Free for 14 days.

Download on the App StoreGet it on Google Play